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What should Patients Know About Self Blood
Pressure Measurement? A Review Article
Sau-Nga Fu*
Department of Family Medicine and Primary Health Care, Kowloon West Cluster, Hospital Authority, Hong Kong

Abstract
Many people measure their blood pressure (BP) outside doctors' ofﬁces with a common goal of concerning their health
status. Self-BP monitoring devices are widely accessible as health care products or available in different community
institutes. Patients often seek their doctors' advice on their BP readings in our daily practice. Current international
guidelines recommend that correct self-BP measurement with validated devices can enhance patients' self-management
and drug compliance, improving overall BP control. While most of the clinicians are supportive of their patients’ efforts,
they are also concerned about the validity and reliability of the out-of-ofﬁce BP readings. How can we effectively educate
patients to get meaningful BP readings, which may improve their overall BP control? This article will review the current
best evidence on patient self-BP monitoring.
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Introduction

H

ypertension is the most prevalent chronic
disease worldwide. The World Health Organization estimated that 1 in 4 men and 1 in 5 women
e over a billion people have hypertension [1]. Uncontrolled blood pressure (BP) leads to signiﬁcant
mortality and morbidity from cardiovascular disease [2]. However, many patients did not achieve
the recommended BP level despite various effective
antihypertensive medications [3]. Most clinicians
can only measure patients' BP in a clinical setting;
therefore, patients' actual BP proﬁle remains challenging to assess [4]. One of the effective strategies
is empowering patients' self-management, which
can engage patients in their own BP control [5].
Patients who participated in self BP monitoring
(SBPM) have demonstrated a reduction in BP levels
in many randomized controlled trials, given that
antihypertensive titration, telemonitoring of BP and
other clinical interventions were offered after SBPM

[6]. Systematic reviews also showed well-controlled
out-of-ofﬁce BP was protective against adverse cardiovascular outcomes [7]. Therefore, it is common to
see the promotion of SBPM devices and regular selfmeasurement in commercial advertisements and
different health care settings.
Who should measure BP themselves?
Current evidence supports the use of SBPM in the
diagnosis and monitoring of hypertension, particularly for patients with white coat hypertension,
masked hypertension and hypertension with white
coat effect [8,9]. The deﬁnition of hypertension
varies among different authorities under different
clinical circumstances [10].The most commonly
accepted deﬁnition is systolic BP  140 mmHg, and/
or diastolic BP  90 mmHg in 2 visits. Whitecoat
hypertension is deﬁned as persistent elevated BP in
a clinical setting with normal out-of-ofﬁce BP. On
the contrary, masked hypertension is deﬁned as
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normal BP in a clinical setting with high out-of-ofﬁce BP. Hypertension with the white coat effect is
when patients on hypertensive treatment have
persistently elevated BP in a clinical setting. Still,
their out-of-ofﬁce BP is within normal ranges. The
treatment target BP is variable according to the
overall cardiovascular risk, existing cardiovascular
events, presence of kidney disease, diabetes mellitus, patients’ tolerance to treatment, and clinical
condition.
Given the above deﬁnitions, all patients on antihypertensive treatment, presented with sometimes
high BP or elevated clinic BPs, are potential candidates for SBPM, no matter if they are newly presented with high BP or already on antihypertensive
treatment. Some patients may report elevated BP in
out-of-ofﬁce settings, such as incidental measurements at home, institutes, or community settings if
they can access a valid BP monitor and they or their
care-takers can perform BP measurement correctly.
Conventionally, ambulatory BP monitoring
(ABPM) is a gold standard option for diagnosing
and monitoring out-of-ofﬁce BP [11]. Table 1
showed the different BP cut-off levels of hypertension diagnosis for clinic BP, 24-h ABPM and SBPM
readings. Clinicians attach ambulatory BP monitors
to patients' upper arms, and BP measurements are
automatically performed once every 30e60 minutes.
Patients can continue their normal daily activities
except during BP measurement. Comparing SBPM
with ABPM, ABPM can also assess the whole day's
BP proﬁle, including active status and sleep time.
The information is essential for patients with highly
ﬂuctuating BP, which require ﬁne medication
adjustment. ABPM devices are professional products with generally higher quality and technical
speciﬁcations. They do not require patients' operations and records. Studies showed both ABPM and
SBPM measurements correlated well with patients'
overall cardiovascular mortality and morbidity outcomes, independent of patients' ofﬁce BP level
[7,12]. However, repeated ABPM may be less
acceptable to patients when compared with SBPM

because of the need for repeated clinic visits and
disturbance to normal daily activities [13].
Beneﬁts and risk of SBPM
SBPM is widely accessible, acceptable and
affordable for people with or without hypertension.
Systematic reviews found that healthcare interventions, including SBPM and patient education,
reduced BP [6]. The process of SBPM education can
engage patients to understand treatment targets and
their overall control. Compared with patients with
no SBPM, those performing SBPM regularly had
better knowledge of hypertension and its complications [14]. Patients’ health literacy should not limit
high-quality SBPM, which may be achieved by
structured patient education [15].
The accuracy of SBPM readings is always clinicians' and patients' concern. Ideally, patients should
select the brachial SBPM devices which have undergone standardized validation [16]. The regularly
updated list of devices is available online. However,
only a minority of commercially available SBPM
devices have been validated. The cost of SBPM devices varies signiﬁcantly among different brands
and models. Many patients encounter difﬁculty in
selecting an appropriate monitor. Patients may
wrongly measure and record BP [17]. Inaccurate
SBPM may mislead doctors' diagnosis and subsequent management. Patients’ responses to BP
readings may also be highly variable. Some patients
may overreact to the readings, while others may
delay seeking medical advice despite persistently
abnormal readings [18].
Clinicians generally support patient self-managementdnevertheless, there is concern in successful transfer of knowledge and skills. There is
also commonly a time constraint for SBPM education. Doctors are expected to review patients' SBPM
readings and manage patients’ BP accordingly. Patients also wish doctors to give feedback on their
homework. Some doctors and nurses may ﬁnd it
difﬁcult to implement in a busy daily practice,

Table 1. Blood Pressure (BP) cut-off for diagnosing hypertension for clinic, 24-hour ambulatory BP monitoring (ABPM) and Self BP monitoring
(SBPM).
Hypertension diagnostic
cut-offa

Systolic BP
(mmHg)

Diastolic BP
(mmHg)

Reference,
Remark

Clinic BP
24-hour ABPM
Daytime (awake)
Nighttime (asleep)
Overall (24-hour)
SBPM

140
135
120
130

90
85
70
85

[9,22,33]
[34]

135

85

[34]

a

The cut-off level is lower for patients with high cardiovascular risk and other comorbidity.
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particularly for those
comorbidities [19].

patients

with

multiple

Common mistakes of SBPM
The common mistakes during SBPM listed in the
literature include inaccurate SBPM machine machine, wrong cuff size, measuring technical errors
such as inadequate rest, the BP monitors not placing
at heart level, cuff position, frequency of measurement, arms are not supported, leg crossing and
reporting errors [20,21]. Many commercially available BP monitors did not pass proper validation
protocols [16]. The general public usually buy
monitors in pharmacies, sales points for health care
equipment, or online shops. If they do not know
how to select, they typically rely on promoters’
recommendation of models, which may or may not
be an appropriate choice. In addition, many
commercially available BP monitors only provide
standard brachial cuffs size.
How should patients be advised on SBPM?
The American College of Cardiology/American
Heart Association, the European Society of Hypertension (ESH), Hypertension Canada, National
Heart Foundation of Australia and the National
Institute for Health and Care Excellence issued
guidelines for the recommendations and procedures for the use of SBPM [8,9,22].
For patients motivated in self-care, clinicians can
ﬁrst advise patients on selecting validated brachial
type SBPM monitors by international standardized
protocols [23]. The British Hypertension Society
(BHS) Protocol, the Association for the Advancement of Medical Instrumentation (AAMI) Standard,
and the International Protocol of the European Society of Hypertension (IP) published a universal,
widely accepted protocol for brachial cuff type BP
monitor validation [24]. In the protocol, at least 85
subjects with different arm circumferences are
recruited from the general population for sequential
BP measurements in different BP ranges. If more
than 85% of the readings have less than 10 mmHg
error, the device is acceptable.
The list of validated BP devices is accessible in
the Dabl Educational Trust and the US Blood
Pressure Validated Device Listing (VDL) [25]. Patients may ﬁnd it difﬁcult to tell if their SBPM
device has been validated. Therefore, the clinician's
recommendations following the list of reliable devices in the market would be helpful. If cost is less
concerned, monitors with sufﬁcient readings
memory or Bluetooth synchronization with mobile
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device functions are preferred. If patients can share
the details of BP records, including time, frequency,
readings, with calculated mean daytime and nighttime BP, clinicians can ensure optimal BP control.
Patient information on the steps of SBPM measurement is shown in Table 2 and Table 3 (Chinese
Version).
Community resources for SBPM
Some patients may prefer SBPM under professional supervision. Other patients may be unable to
perform SBPM because of physical, mental or literacy limitations. Clinicians may consider introducing their patients in Hong Kong to visit the
District Health Centres (DHC) [26]. Currently, the
Kwai Tsing, Tuen Mun, Wong Tai Sin and Sham
Shui Po DHC operate until late evening. Besides,
when there is less concern in the COVID pandemic,
self-BP monitors are available for public use in some
health care institutes or sports venues. Non-government organizations have provided a Patient
Empowerment Program for patients with diabetes
since 2010. Structured disease knowledge and selfcare education are developed to motivate patients
[27]. Registered nurses train participants and their
family members about self-BP monitoring.
New advances in out-of-ofﬁce BP monitoring
Given limitation in ABPM and SBPM, new advances in wearable digital blood pressure monitors
with minimal stress on the patient is a global trend
in the digital era. They are not yet accepted in
clinical use because of limited evidence and validation protocol [28].
Oscillometric measurement at the wrist is similar to
the conventional SBPM and ABPM brachial devices.
The regular stress to the wrist is less disturbing than
the brachial devices. Several validation studies of the
wrist device were published using international BP
device validation protocols [29].
Applanation tonometry method uses radial arterial wall applanation to measure the waveform of
arterial BP [30]. The sensor must be stabilized at the
wrist, and no patient movement is allowed during
measurement. The most common application is to
measure night-time BP surges, especially in patients
with sleep apnea [31].
Photoplethysmography sensors can be worn over
ﬁngers or wrists. There are ongoing studies on the
multiple site cufﬂess photoplethysmography measurement [32]. The pulse transit time of the arterial
pulse wave in different sites can be used to estimate
the BP proﬁle.
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Table 2. Self BP Monitoring checklist.
No
1.

2.
3.

4.
5.
6.

7.

✓

;

✓

;

No exercise, smoke or consume foods or drinks containing caffeine (such as tea or coffee) at least
30 min. Rest at least 5 min Wear loose-ﬁtting and comfortable clothes, Roll up the sleeve to expose
your upper arm
Choose a stable table and chair of appropriate height (at heart level) with arm rest. Sit comfortably
and relaxed with your back supported, keep your feet on the ﬂoor and do not cross the legs
Check if the cuff size and cuff position is appropriate (ﬁts the arm within the accepted range
indicated on the cuff with appropriate tightness. The lower border of the cuff should be 2 cm above
the pit of elbow, which is approximately two ﬁnger-breadths. Make sure the tubing is placed at the
centre of your arm facing the front and that the sensor is correctly placed. Patient can just slip two
ﬁngertips beneath the cuff, near its edge at the top end
no talking/movement during measurement, after complete release of cuff, repeat measurement at
least 1 min apart
Record all readings accurately
Record Schedule:
 Twice daily: before taking medicine and before dinner
 Daily after change in treatment regimen for 2 weeks þ Daily for one week before clinic visit
 Measure at least 7 days [22,34]
Web-base resources:
BHS British Hypertension Society https://bihsoc.org/wp-content/uploads/2017/09/How_to_
instructional_leaﬂet.pdf
AHS American Heart Association https://www.heart.org/en/health-topics/high-blood-pressure/
understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home
RACGP Royal Australian College of General Practitioners: https://www.racgp.org.au/download/
Documents/AFP/2016/January/February/Clinical-Sharman.pdf

Table 3. Self BP Monitoring checklist (Chinese Version).
No
1.
2.
3.

4.
5.
6.

量度血壓30分鐘前請勿吸煙或飲用含咖啡因食品(咖啡或茶), 最少休息5分鐘, 穿著鬆身衣物, 衫袖卷高。
舒適地安坐在有椅背及扶手的椅子上, 雙腳平放在地上
把血壓機平放在心臟水平的桌面上, 把血壓機袖帶包好
選擇適當大小的血壓機帶, 帶長度應能完全包裹手臂, 不宜太鬆或太緊。包好後剛好能在帶內放下兩隻手
指
帶應包在手踭兩公分以上, 連接血壓機的膠管要放在手臂正中央前方
量度時不應移動或講話, 量度完後1分鐘後待帶完全放鬆後, 再按鈕量度一次
準確地記錄所有血壓
每日量度兩次:早上服藥前及晚飯前
建議在覆診前一星期量度７天（量度最少１２次）

Conclusion
Current international guidelines recommend accurate SBPM as a diagnostic and monitoring
investigation in patients with high-normal and
elevated BP, whether they are on antihypertensive
drugs or not. Patients should be trained with the
proper SBPM technique and recommended a validated SBPM device. Physicians’ response and action
according to patients’ SBPM records could engage
patients for better drug compliance and more

healthy lifestyle activities. We may be able to apply
the latest advances in non-invasive BP monitoring
in daily practice very soon.
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